MedTrace Logo

Safety and Efficacy of Methoxyflurane for Treatment of Incident Pain

NCT00524927 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 110

Last updated 2010-01-28

No results posted yet for this study

Summary

This study aims to provide further supportive evidence that Methoxyflurane, a potent analgesic, administered using the Penthrox Inhaler is safe and efficacious in adult participants, specifically those who experience incident pain associated with a planned bone marrow biopsy.

Conditions

  • Pain Measurement

Interventions

DRUG

Methoxyflurane

DRUG

Normal Saline

Sponsors & Collaborators

  • Australian Department of Industry, Tourism and Resources

    collaborator INDUSTRY

  • Medical Developments International Limited

    lead INDUSTRY

Principal Investigators

  • Odette Spruyt, MD · Peter MacCallum Cancer Centre, Australia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Completion
2009-11-30

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00524927 on ClinicalTrials.gov